// App-Quantinova.ai

SAT-094 : OUTCOMES OF ONCE DAILY IMMUNOSUPPRESSION IN YOUNG ADULTS WITH RENAL TRANSPLANTS

Researchers

Presenter

  • T. KWAN

Principal Investigators

  • M. Brook

  • P. Harden

Medical Centers

  • Oxford University, Renal Medicine, Oxford, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Oraprine

  • Alemtuzumab

  • Tacrolimus

Outcome

  • N/A

Study Design

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved